Strategic Advocates »

Fulgent Genetics shares owned by Strategic Advocates

Quarter-by-quarter ownership of Fulgent Genetics (FLGT) shares owned by Strategic Advocates from 13F filings

Historical chart of Strategic Advocates investment in Fulgent Genetics

Tip: Access up to 7 years of quarterly data

All positions including Fulgent Genetics held by Strategic Advocates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fulgent Genetics by Strategic Advocates

Quarter filed Position value Share count Share price at filing
2025-09-30 $14k 622 22.60

More positions owned by Strategic Advocates

State Street Spdr S&p Kensho New Economies Composite Etf Etf (KOMP)
Invesco Qqq Trust Series I Etf (QQQ)
Vanguard Intermediate-term Bond Etf Etf (BIV)
Invesco S&p 500 Pure Value Etf Etf (RPV)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)
State Street Spdr Portfolio Long Term Corporate Bond Etf Etf (SPLB)
Vanguard S&p Small-cap 600 Growth Etf Etf (VIOG)
Ishares 1-5 Year Investment Grade Corporate Bond Etf Etf (IGSB)
Nvidia Corporation Stock (NVDA)
Apple Stock (AAPL)
Palantir Technologies Inc Cl A Stock (PLTR)
Tesla Stock (TSLA)
Pimco 0-5 Year High Yield Corporate Bond Index Exchange-traded Fund Etf (HYS)
Amazon Stock (AMZN)
Meta Platforms Inc Cl A Stock (META)

View all positions for Strategic Advocates

Top funds holding Fulgent Genetics

BlackRock
Millennium Management
Vanguard Group
Acadian Asset Management
Dimensional Fund Advisors
D. E. Shaw & Co
Deutsche Bank Aktiengesellschaft
State Street Corporation
Geode Capital Management
Ameriprise Financial
Citadel Advisors
Point72 Asset Management
Charles Schwab Investment Management
Connor, Clark & Lunn Investment Management
Jpmorgan Chase & Co

View all funds holding Fulgent Genetics